Clinical Trial Update: A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 study evaluating DC-TAB for safety and efficacy in Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• DC-TAB

Snippet

Sponsor: Delta Crystallon BV | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED